Clinical Trial Update: A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating iMSC to prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation; currently not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• iMSC

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Graft-versus-Host Disease | EARLY_Phase 1 | Status: NOT_YET_RECRUITING